Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 14, 2025 04:34 ET | Source: Prometheus

Prometheus Launches First-Of-Its-Kind 2X Your Crypto Today Luxury Real Estate Program for Crypto & Bitcoin Only Investors

LOS ANGELES, March 14, 2025 (GLOBE NEWSWIRE) -- Prometheus, the top-tier award winning Portuguese ultra luxury real estate developer and leader in home innovation, has unveiled a groundbreaking home...
August 11, 2022 16:00 ET | Source: Prometheus Biosciences

Prometheus Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress

- Both topline ARTEMIS-UC Phase 2 and full APOLLO-CD Phase 2a results expected concurrently in 4Q 2022 - - Bioavailability greater than 80% achieved upon completion of PRA023 subcutaneous bridging...
March 23, 2022 10:56 ET | Source: tribe29 GmbH

2,000 official plug-ins for Checkmk: Presenting the Prometheus Alert Manager

MUNICH, Germany, March 23, 2022 (GLOBE NEWSWIRE) -- tribe29, the company behind the Checkmk IT monitoring solution, today presented the Prometheus Alert Manager as its official Checkmk monitoring...
January 05, 2022 08:30 ET | Source: Prometheus Biosciences

Prometheus Biosciences to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
January 03, 2022 08:00 ET | Source: Prometheus Biosciences

Prometheus Biosciences and Dr. Falk Pharma Advance PR600 and Trigger Final Preclinical Milestone Payment

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
December 07, 2021 07:00 ET | Source: Prometheus Biosciences

Prometheus Biosciences Reports Positive Topline Phase 1 Data on Lead Therapeutic Candidate PRA023; Expands Indications to Include Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

Phase 1 trial achieved primary objective of safety and tolerability and demonstrated favorable outcomes on other key endpoints, including target engagement and immunogenicity Discussion of Phase 1...
July 08, 2021 10:14 ET | Source: QOMPLX, Inc.

QOMPLX Announces Prometheus Integration for its High-Performance, Cost-Efficient Time Series Database

TYSONS, Va., July 08, 2021 (GLOBE NEWSWIRE) -- QOMPLX™ is proud to announce the integration of the popular and powerful systems monitoring & alerting toolkit Prometheus with TimeEngine, QOMPLX’s...
September 17, 2020 11:30 ET | Source: Grafana

Grafana Labs Releases Grafana Metrics Enterprise, a Streamlined, Cost-Effective Way for Organizations to Run Prometheus at Enterprise Scale

NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Today, Grafana Labs announced the release of Grafana Metrics Enterprise, a modern Prometheus-as-a-Service solution designed for the scale, architecture,...
May 18, 2020 11:30 ET | Source: Grafana

Grafana 7.0 Delivers Major Visualization Upgrades and Empowers Users to Unite & Transform Data from All Sources Ranging from Metrics and Logs to Traces and Beyond

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- Today, Grafana Labs is announcing the general availability of Grafana 7.0 with significant enhancements to simplify the development of custom plugins and...
February 27, 2018 06:00 ET | Source: Sysdig

Sysdig Announces Expanded Prometheus Support Options

SAN FRANCISCO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Sysdig, Inc., the container intelligence company, today announced new customizable support packages for self-hosted Prometheus monitoring users....